Eradicating Quiescent Tumor Cells by Targeting Mitochondrial Bioenergetics.

作者: Xiaonan Zhang , Angelo De Milito , Asuman Demiroglu-Zergeroglu , Joachim Gullbo , Padraig D’Arcy

DOI: 10.1016/J.TRECAN.2016.10.009

关键词: CancerCellImmunologyBioenergeticsBiologyOxidative phosphorylationDisease EradicationCancer researchHypoxia (medical)Cancer stem cellFlux (metabolism)

摘要: The presence of quiescent cell populations in solid tumors represents a major challenge for disease eradication. Such cells are generally present poorly vascularized tumor areas, show limited sensitivity to traditional chemotherapeutical drugs, and tend resume proliferation, resulting reseeding growth. There is growing recognition the importance developing therapies that target these achieve long-lasting remission. Recent studies have shown combination hypoxia reduced nutrient availability areas results metabolic plasticity coupled with an increased perturbations mitochondrial flux. Targeting bioenergetics may enable eradication improve prognosis patients cancer.

参考文章(62)
M Robiolio, W L Rumsey, D F Wilson, E M Nuutinen, C Schlosser, Cellular energetics and the oxygen dependence of respiration in cardiac myocytes isolated from adult rat. Journal of Biological Chemistry. ,vol. 265, pp. 15392- 15399 ,(1990) , 10.1016/S0021-9258(18)55409-0
Sheetal Parida, Mahitosh Mandal, Abstract 3685: Managing cervical cancer using multifunctional gold nanorods Cancer Research. ,vol. 75, pp. 3685- 3685 ,(2015) , 10.1158/1538-7445.AM2015-3685
Cyril Corbet, Olivier Feron, Metabolic and mind shifts: from glucose to glutamine and acetate addictions in cancer. Current Opinion in Clinical Nutrition and Metabolic Care. ,vol. 18, pp. 346- 353 ,(2015) , 10.1097/MCO.0000000000000178
Rebecca Lamb, Bela Ozsvari, Camilla L. Lisanti, Herbert B. Tanowitz, Anthony Howell, Ubaldo E. Martinez-Outschoorn, Federica Sotgia, Michael P. Lisanti, Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: Treating cancer like an infectious disease Oncotarget. ,vol. 6, pp. 4569- 4584 ,(2015) , 10.18632/ONCOTARGET.3174
Isao Momose, Shun-ichi Ohba, Daisuke Tatsuda, Manabu Kawada, Tohru Masuda, Go Tsujiuchi, Takao Yamori, Hiroyasu Esumi, Daishiro Ikeda, Mitochondrial inhibitors show preferential cytotoxicity to human pancreatic cancer PANC-1 cells under glucose-deprived conditions Biochemical and Biophysical Research Communications. ,vol. 392, pp. 460- 466 ,(2010) , 10.1016/J.BBRC.2010.01.050
Yuan Gu, Chunting Qi, Xiaoxiao Sun, Xiuquan Ma, Haohao Zhang, Lihong Hu, Junying Yuan, Qiang Yu, Arctigenin preferentially induces tumor cell death under glucose deprivation by inhibiting cellular energy metabolism. Biochemical Pharmacology. ,vol. 84, pp. 468- 476 ,(2012) , 10.1016/J.BCP.2012.06.002
F. Weinberg, R. Hamanaka, W. W. Wheaton, S. Weinberg, J. Joseph, M. Lopez, B. Kalyanaraman, G. M. Mutlu, G. R. S. Budinger, N. S. Chandel, Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity Proceedings of the National Academy of Sciences of the United States of America. ,vol. 107, pp. 8788- 8793 ,(2010) , 10.1073/PNAS.1003428107